Modulation of the ATP-lnduced release and processing of IL-1beta in microglial cells

Takato Takenouchi1, Shuei Sugama, Yoshifumi Iwamaru

  • 1Transgenic Animal Research Center, National Institute of Agrobiological Sciences, Ohwashi, Tsukuba, Ibaraki, Japan

Insights

Interleukin-1 beta (IL-1beta) release from microglia involves the P2X7 receptor (P2X7R). Lysophospholipids modulate this process, offering potential therapeutic targets for neuroinflammation and neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Interleukin-1 beta (IL-1beta) is a potent pro-inflammatory cytokine primarily released by activated microglia in the brain.
  • IL-1beta plays a critical role in the pathogenesis of neurodegenerative disorders.
  • Understanding IL-1beta release mechanisms is crucial for developing therapeutic strategies for neuroinflammatory diseases.

Purpose of the Study:

  • To review the regulatory mechanisms of IL-1beta maturation and release from microglial cells.
  • To elucidate the role of the P2X7 receptor (P2X7R) in IL-1beta release.
  • To highlight the involvement of lysophospholipids in P2X7R-dependent IL-1beta release.

Main Methods:

  • Literature review of studies on microglial IL-1beta release.
  • Focus on P2X7R signaling pathways.
  • Analysis of lysophospholipid modulation of IL-1beta secretion.

Main Results:

  • IL-1beta is released from microglia independently of the classical endoplasmic reticulum/Golgi pathway.
  • The P2X7 receptor (P2X7R) is a key mediator in the release of mature IL-1beta.
  • Lysophospholipids emerge as significant modulators of P2X7R-dependent IL-1beta release.

Conclusions:

  • P2X7R signaling is central to microglial IL-1beta release.
  • Lysophospholipids represent novel targets for modulating neuroinflammation via P2X7R.
  • Targeting P2X7R and lysophospholipid pathways may offer therapeutic avenues for neurodegenerative diseases.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...